Loading…
Academic Journal
AUTOLOGOUS PLATELET-RICH PLASMA IN THE TREATMENT OF PATIENTS WITH KNEE ARTHRITIS III STAGE
D. A. Malanin, V. V. Novochadov, S. Demkin, M. V. Demeshenko, D. I. Danilov
Travmatologiâ i Ortopediâ Rossii, Vol 0, Iss 3, Pp 52-59 (2016)
Saved in:
| Title | AUTOLOGOUS PLATELET-RICH PLASMA IN THE TREATMENT OF PATIENTS WITH KNEE ARTHRITIS III STAGE |
|---|---|
| Authors | D. A. Malanin, V. V. Novochadov, S. Demkin, M. V. Demeshenko, D. I. Danilov |
| Publication Year |
2016
|
| Source |
Travmatologiâ i Ortopediâ Rossii, Vol 0, Iss 3, Pp 52-59 (2016)
|
| Description |
The purpose of the study - to determine the effectiveness of using PRP in the treatment of patients with stage III knee arthritis. Material for the study - 81 patients , two clinical groups with unilateral ( 9 patients - 15%) or bilateral ( 51 patients - 85%) with stage III knee arthritis. The first group of patients in an amount of 40 people were treated by introducing into the knee joint of autologous platelet-rich plasma 1 every three weeks. In the comparison group of 41 patients were symptomatic treatment with non-steroidal anti-inflammatory drugs. Evaluation of the results was performed using the LEKEN scale, VAS, verbal evaluation of the effectiveness of pain at 3, 6, 9 weeks after the treatment. Results: satisfactory result has increased to 52.5 %±0.2% of patients in week 9 of the main group. Score VAS and LEKEN scale gives a clear picture to the marked reduction in pain 9 weeks to 4 observation points. Intraarticular injection of PRP in the treatment of patients with stage III can reduce the severity of pain, improve knee function and quality of life for 9 weeks during their preparation for surgical treatment. Adherence to treatment of patients with stage III receiving intraarticular PRP, close to 98%.
|
| Document Type |
article
|
| Language |
Russian
|
| Publisher Information |
Vreden Russian Research Institute of Traumatology and Orthopedics, 2016.
|
| Subject Terms | |
